Trials / Completed
CompletedNCT02737800
Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients
Effect of Prolonged GnRh Agonist Therapy on the Outcome of In-Vitro Fertilization& Embryo Transfer in Endometrioma Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Investigators compare ICSI results for endometrioma patients with or without cyst aspiration if more than 5cm \&with or without GnRh agonists for all endometrioma patients
Detailed description
Group 1 consists of 30 patients of endometrioma more than 5cm subdivided into: Group 1A;Cyst aspiration followed by standard long protocol in 15 patients Group 1B;Cyst aspiration followed by GnRh suppression for 3 months then standard long protocol in 15 patients Group 2 consists of 30 patients of endometrioma less than 5cm subdivided into : Group 2A;no intervention to the cyst. Standard long protocol Group 2B;GnRh suppression for 3 months then standard long protocol
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | endometrioma aspiration | Transvaginal ultrasound guided aspiration |
| DRUG | GnRh agonist ( Decapeptyl ) | 3 monthly doses of Decapeptyl 7.5mg intramuscular |
| PROCEDURE | standard long stimulation protocol | Decapeptyl 3.75mg in the mid luteal phase followed by human menopausal gonadotropins(HMG);fostimon, or merional injections after bleeding, doses are individualization according to each patient, monitored by follicular size \&serum estradiol. |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-04-14
- Last updated
- 2018-07-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02737800. Inclusion in this directory is not an endorsement.